SCHEMBL16834262

SCHEMBL16834262

O=C(O)Oc1cccc(C(F)(F)F)n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 1/20 0.46
TAS2R14 Q9NYV8 2/20 0.43
LOXL2 Q9Y4K0 2/20 0.39
AHR P35869 1/20 0.38
SCN9A Q15858 2/20 0.38
SCN7A Q01118 1/20 0.38
KCNH2 Q12809 1/20 0.38
PGK1 P00558 1/20 0.38
PGK2 P07205 1/20 0.38
HCRTR1 O43613 1/20 0.36
HCRTR2 O43614 1/20 0.36
KDM4E B2RXH2 1/20 0.36
HPGD P15428 1/20 0.36
FPR2 P25090 1/20 0.36
GSK3A P49840 2/20 0.36
GSK3B P49841 2/20 0.36
SRPK1 Q96SB4 2/20 0.36
MAP4K4 O95819 2/20 0.36
CSNK2A1 P68400 2/20 0.36
HIPK4 Q8NE63 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19029855 0.86 PGK1 (0.36) P2RX7TAS2R14LOXL2SCN9ASCN7A
SCHEMBL27908935 0.84 P2RX7 (0.45) P2RX7TAS2R14LOXL2AHRSCN9A
SCHEMBL2635567 0.84 P2RX7 (0.49) P2RX7TAS2R14LOXL2AHRSCN9A
SCHEMBL377165 0.82 KDM4E (0.44) KDM4E
SCHEMBL18952270 0.80 PIM1 (0.36) KDM4EHPGDPIM1
SCHEMBL27682858 0.80 NPC1 (0.54) P2RX7TAS2R14LOXL2
SCHEMBL32682038 0.78 KMT2A (0.46) P2RX7TAS2R14LOXL2KDM4EHPGD
SCHEMBL22397018 0.78 KMT2A (0.46) P2RX7TAS2R14LOXL2KDM4EHPGD
SCHEMBL1959613 0.76 ALDH1A1 (0.33) PGK1PGK2KDM4E
SCHEMBL7973413 0.76 CYP11B1 (0.42) SCN9AKDM4EFPR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3674298-B9 SUBSTITUTED INDAZOLES, PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL FORMULATIONS CONTAINING THEM, AND THEIR USE FOR THE PREPARATION OF MEDICAMENTS Bayer Pharma AG (DE) 2024-06-19 EP disclosed
EP-3674298-B1 SUBSTITUTED INDAZOLES, PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL FORMULATIONS CONTAINING THEM, AND THEIR USE FOR THE PREPARATION OF MEDICAMENTS Bayer Pharma AG (DE) 2024-01-10 EP disclosed
EP-4260909-A2 SUBSTITUTED INDAZOLES, PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL PREPARATIONS CONTAINING THEM AND THEIR USE IN THE PREPARATION OF DRUGS Bayer Pharma Aktiengesellschaft (DE) 2023-10-18 EP disclosed
EP-3423446-B1 NEW 2-SUBSTITUTED INDAZOLES, METHODS FOR PRODUCING SAME, PHARMACEUTICAL PREPARATIONS THAT CONTAIN SAME, AND USE OF SAME TO PRODUCE DRUGS Bayer Pharma AG (DE) 2020-09-16 EP disclosed
EP-3674298-A1 SUBSTITUTED INDAZOLES, PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL FORMULATIONS CONTAINING THEM, AND THEIR USE FOR THE PREPARATION OF MEDICAMENTS Bayer Pharma Aktiengesellschaft (DE) 2020-07-01 EP disclosed
EP-3224254-B1 SUBSTITUTED INDAZOLES, PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL FORMULATIONS CONTAINING THEM, AND THEIR USE FOR THE PREPARATION OF MEDICAMENTS Bayer Pharma AG (DE) 2020-04-15 EP disclosed
EP-3463354-A1 USE OF 2-SUBSTITUTED INDAZOLES FOR THE TREATMENT AND PROPHYLAXIS OF AUTOIMMUNE DISEASES Bayer Pharma Aktiengesellschaft (DE) 2019-04-10 EP disclosed
EP-3423446-A1 NEW 2-SUBSTITUTED INDAZOLES, METHODS FOR PRODUCING SAME, PHARMACEUTICAL PREPARATIONS THAT CONTAIN SAME, AND USE OF SAME TO PRODUCE DRUGS Bayer Pharma Aktiengesellschaft (DE) 2019-01-09 EP disclosed
EP-3083586-B1 NOVEL CARBOXAMIDES, METHOD FOR THE PRODUCTION THEREOF, PHARMACEUTICAL PREPARATIONS COMPRISING THEM, AND USE THEREOF FOR PRODUCING MEDICAMENTS Bayer Pharma AG (DE) 2018-04-18 EP disclosed
WO-2018060072-A1 NEW SUBSTITUTED BENZIMIDAZOLES, METHODS FOR THE PRODUCTION OF SAME, PHARMACEUTICAL PREPARATIONS CONTAINING SAME, AND USE OF SAME TO PRODUCE DRUGS BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2018-04-05 WO disclosed
WO-2018060174-A1 SUBSTITUTED BENZIMIDAZOLES, PHARMACEUTICAL PREPARATIONS CONTAINING SAME, AND USE OF SAME TO PRODUCE DRUGS BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2018-04-05 WO disclosed
WO-2017207385-A1 SUBSTITUTED 3-METHYLINDAZOLES, METHODS FOR THE PRODUCTION THEREOF, PHARMACEUTICAL PREPARATIONS CONTAINING SAME, AND USE THEREOF FOR THE PRODUCTION OF MEDICAMENTS BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2017-12-07 WO disclosed
WO-2017207386-A1 USE OF 2-SUBSTITUTED INDAZOLES FOR THE TREATMENT AND PROPHYLAXIS OF AUTOIMMUNE DISEASES BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2017-12-07 WO disclosed
EP-3224254-A1 NEW SUBSTITUTED INDAZOLES, METHODS FOR THE PRODUCTION THEREOF, PHARMACEUTICAL PREPARATIONS THAT CONTAIN SAID NEW SUBSTITUTED INDAZOLES, AND USE OF SAID NEW SUBSTITUTED INDAZOLES TO PRODUCE DRUGS Bayer Pharma Aktiengesellschaft (DE) 2017-10-04 EP disclosed
EP-3195865-A1 COMBINATIONS OF INHIBITORS OF IRAK4 WITH INHIBITORS OF BTK Bayer Pharma Aktiengesellschaft (DE) 2017-07-26 EP disclosed
WO-2017108744-A1 NOVEL SUBSTITUTED INDAZOLES, METHODS FOR PRODUCING SAME, PHARMACEUTICAL PREPARATIONS THAT CONTAIN SAME, AND USE OF SAME TO PRODUCE DRUGS BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2017-06-29 WO disclosed
EP-3083586-A1 NOVEL CARBOXAMIDES, METHOD FOR THE PRODUCTION THEREOF, PHARMACEUTICAL PREPARATIONS COMPRISING THEM, AND USE THEREOF FOR PRODUCING MEDICAMENTS Bayer Pharma Aktiengesellschaft (DE) 2016-10-26 EP disclosed
WO-2016083433-A1 NEW SUBSTITUTED INDAZOLES, METHODS FOR THE PRODUCTION THEREOF, PHARMACEUTICAL PREPARATIONS THAT CONTAIN SAID NEW SUBSTITUTED INDAZOLES, AND USE OF SAID NEW SUBSTITUTED INDAZOLES TO PRODUCE DRUGS BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2016-06-02 WO disclosed
WO-2015091426-A1 NOVEL CARBOXAMIDES, METHOD FOR THE PRODUCTION THEREOF, PHARMACEUTICAL PREPARATIONS COMPRISING THEM, AND USE THEREOF FOR PRODUCING MEDICAMENTS BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2015-06-25 WO disclosed